Anti-melanoma differentiation-associated gene 5 (anti-MDA5) is a myositis-specific autoantibody seen in 10–35% of patients with dermatomyositis.1 The clinical spectrum of Anti-MDA 5 associated dermatomyositis is diverse and depends on the ethnicity of the study population. Here, IFIH1 is linked to dermatomyositis.